NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 09/10/2026 15:29
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization16,516 mln
Float22.37 mln
Earnings Date10/26/2026
EPS
17.03
Robust
P / E
34.25
Overvalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.89
Likely reliable
1-Year Forecast
582
Fairly priced
Relative Strength
25
/ 100
Underperforming
Business Description
Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace Holdings helps pharmaceutical, biotechnology, and medical device companies bring new treatments to market. The company manages the full range of clinical trial stages across more than six continents, handling everything from study design and regulatory submissions to laboratory testing, data analysis, and patient safety monitoring. Medpace also provides specialized support services including human pharmacology studies, medical imaging, and heart monitoring for clinical trials.
